Pursuit Wealth Management’s AbbVie ABBV Stock Holding History

Pursuit Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$789K	Buy	+3,452	New	+$786K	0.68%	45

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Pursuit Wealth Management's ABBV Position: Q4 2025 in Review

Pursuit Wealth Management opened a new position in AbbVie (ABBV) in Q4 2025: 3,452 shares worth $789K. The stake represents 0.68% of the portfolio and ranks #45 among its holdings.

4,148 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

Pursuit Wealth Management held 3,452 shares of AbbVie worth $789K as of Q4 2025.
AbbVie was a new Pursuit Wealth Management position in Q4 2025.
AbbVie made up 0.68% of Pursuit Wealth Management's portfolio in Q4 2025, its #45 holding.
4,148 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Pursuit Wealth Management's 13F filing for Q4 2025, filed 26 Jan 2026.